Practice
Featured experience
FTC clearance of Novo Nordisk acquisition of certain Catalent sites
We secured regulatory approval following a lengthy review
Syngenta antitrust litigation victory
We secured the dismissal of a price-fixing antitrust suit
Favorable plea deal for paving company in bid-rigging case
We represented the defendant in a DOJ antitrust investigation, securing a favorable plea deal
Antitrust advice to AI company
We are advising our client on a range of antitrust issues
Bansk Group $1.5 billion going-private acquisition of PetIQ
We are advising Bansk Group on the transaction
VF $1.5 billion sale of Supreme to EssilorLuxottica
We are advising VF on the transaction
Cleveland-Cliffs $2.5 billion acquisition of Stelco Holdings
We are advising Cleveland-Cliffs on the acquisition
Emerson $3.5 billion sale of remaining interests in Copeland to Blackstone
We are advising Emerson on the sale
Dismissal of $110 million expropriation action against Central Bank of Curaçao
Davis Polk secured a dismissal of all claims against our client, the Central Bank of Curaçao and Sint Maarten
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
GHK $520 million sale of Supreme Cabinetry Brands to MasterBrand
We are advising GHK Capital Partners and Supreme Cabinetry Brands on the transaction
AC Immune exclusive option and license agreement with Takeda Pharmaceuticals
We advised AC Immune on the transaction
Uniti Group merger with Windstream
We are advising Uniti Group on the transaction